EXANE DERIVATIVES - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 184 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$481,000
-89.9%
12
-90.6%
0.00%
-100.0%
Q1 2022$4,775,000
-26.0%
128
-21.0%
0.00%
-50.0%
Q4 2021$6,452,000
-86.7%
162
-87.5%
0.00%
-83.3%
Q3 2021$48,371,000
-29.6%
1,300
-17.8%
0.01%
-25.0%
Q2 2021$68,689,000
-8.3%
1,5820.0%0.02%
-23.8%
Q1 2021$74,904,000
-22.4%
1,5820.0%0.02%
-25.0%
Q4 2020$96,545,000
-42.5%
1,582
-55.9%
0.03%
-42.9%
Q3 2020$167,870,000
+95.7%
3,591
+112.4%
0.05%
+113.0%
Q2 2020$85,796,000
+13.7%
1,6910.0%0.02%
+9.5%
Q1 2020$75,432,000
-24.6%
1,691
-12.9%
0.02%
+10.5%
Q4 2019$99,980,0001,9420.02%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,750,000$84,053,0007.32%
RTW INVESTMENTS, LP 3,832,480$184,074,0006.94%
Burrage Capital Management LLC 195,725$9,401,0006.30%
Asymmetry Capital Management, L.P. 55,408$2,661,0004.77%
SECTORAL ASSET MANAGEMENT INC 328,738$15,789,0002.36%
ARMISTICE CAPITAL, LLC 758,000$36,407,0002.10%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 114,000$5,470,0001.97%
Opaleye Management Inc. 191,000$9,174,0001.80%
Sofinnova Investments, Inc. 517,092$24,836,0001.79%
Chubb Ltd 8,180$393,0001.68%
View complete list of PTC THERAPEUTICS INC shareholders